Ethical and Regulatory Considerations in Neuropharmacology

This track invites submissions that explore the ethical and regulatory challenges associated with neuropharmacology research and drug development. Researchers should focus on issues such as informed consent, patient safety, and the approval process for new therapies. The track will cover both the ethical implications of emerging technologies, such as gene editing and AI, and the regulatory landscape for neuropharmacology. Attendees will gain insights into the complexities of navigating the ethical and regulatory environment in neuropharmacology, and the importance of balancing innovation with patient protection.

    Related Conference of Ethical and Regulatory Considerations in Neuropharmacology

    August 28-29, 2025

    10th World Kidney Congress

    London, UK
    November 03-04, 2025

    29th European Nephrology Conference

    Rome, Italy
    December 10-11, 2025

    12th World Congress on Epidemiology & Public Health

    Amsterdam, Netherlands
    March 09-10, 2026

    17th Nephrology,Renal Medicine & Renal Care

    Dubai, UAE
    March 26-27, 2026

    22nd World Nephrology Conference

    Amsterdam, Netherlands
    June 29-30, 2026

    18th World Nephrology Summit

    Aix-en-Provence, France

    Ethical and Regulatory Considerations in Neuropharmacology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in